# Prothea Technologies: Medical devices, Milan, Italy > Prothea Technologies: Prothea Technologies is a private medical technology company based in the United Kingdom. Based in Milan, Italy. Source: https://millionrounds.com/startup/prothea-technologies (Millionrounds; every figure on the page links to its filing or article) Italy · [Medical devices startup](https://millionrounds.com/companies) # Prothea Technologies Prothea Technologies is a private medical technology company based in the United Kingdom. Email Funding reported Last round: Series A Medical devices Milan, Italy Follow Prothea Technologies and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fprothea-technologies) Company summary - **Founded:** - not reported - **Team:** 23 11 to 50 people - **Funding reported:** 19.2M as listed, currency not stated - **Last round:** Series A Dec 2025 How sure we are - ✓ **Listed** We know it exists and what it does - 2 **Funding reported** A company dataset reports a raise - 3 **Observed** A filing or a dated announcement confirms a round No round for Prothea Technologies has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology) ## About Prothea Technologies Prothea Technologies is a private medical technology company based in the United Kingdom. It specializes in an integrated platform designed for lung cancer biopsy, diagnosis, and treatment, all within a single hospital visit. This innovative approach significantly reduces the time-to-treat from weeks to minutes, addressing delays and inaccuracies in traditional workflows for patients with suspected early-stage lung cancer. Founded in April 2024 as a spinout from the Universities of Bath and Edinburgh, Prothea has secured €12M ($13M) in Series A funding. The company employs a team of 11-20 people and has an estimated annual revenue of $1.6M. Its core technology features a medical device that combines a Microendoscope with an Image Processing System, allowing for real-time visualization of tissue structure during biopsy. This technology is enhanced by proprietary AI software that provides insights during procedures. Prothea is also developing future solutions, including a laser ablation catheter for immediate treatment of lesions. ## What company datasets say Prothea Technologies raised Funding, as reported Reported in all **19.2M** in the source's currency Last round **Series A** Last round size **6M** Last round date **Dec 2025** Investors listed **4** ## Founders and team From Prothea Technologies's own website: 17 on the team. - **Anne Moore** Chief Operating & Finance Officer - **Jim Stone** Chief Technical Officer - **Professor Kev Dhaliwal** Chief Medical and Chief Scientific Officer - **Annya Bruce** Head of Clinical Affairs - **Charlotte Parry** Head of Fibre Engineering - **Fabian Klarner** VP Engineering, Manging Director Prothea Technologies GmbH - **Gareth Williams** VP Systems Research and Development - **Harry Wood** Head of Fibre - **Hazel Stewart** Head of Systems Engineering - **Joel Collins** Head of Software - **Qiang Wang** Head of Artificial Intelligence R&D - **Vikki Young** VP Regulatory & Quality Affairs - **Crispin Simon** Executive Chair - **Hilola Hakimova** Quality Manager - **John Yianni** Non-Executive Director - **Peter Stratford** Non-Executive Director - **Yoann Bonnamour** Non-Executive Director ## On a portfolio page Investors who name them - [Merieux Equity Partners](https://millionrounds.com/fund/merieux-equity-partners) Each firm lists Prothea Technologies on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source. ## The company, in detail What they build Known for health care biopsy system real-time imaging real-time biopsy guidance manufacturing fluorescence lifetime imaging medical research medical equipment manufacturing tissue characterization microendoscope molecular analysis hospital & health care regulatory development optical endomicroscopy in situ tissue analysis health Built with from their website Google Maps LiteSpeed WordPress.org Font Awesome MailChimp CloudFlare Viewport Meta Varnish Apple Business Manager Google Maps Platform +8 more CloudFlare CDN OWL Carousel Priority Hints Google Font API Microsoft Exchange Autodesk Cloudflare Insights MySQL - **Sector:** Medical devices - **Industry code:** NAICS 339112, SIC 3844 - **Region:** Lombardy ## Medical devices in Italy Startups like it - [**GreenBone Ortho** Roncadelle · founded 2015 *Raised*](https://millionrounds.com/company/greenbone-ortho) - [**InnovHeart** Milan · founded 2015](https://millionrounds.com/startup/innovheart) - [**WISE SpA** Cologno Monzese · founded 2011](https://millionrounds.com/startup/wise-spa) - [**BetaGlue Therapeutics** Milan · founded 2016](https://millionrounds.com/startup/betaglue-therapeutics) - [**DIALYBRID** Cantu · founded 2020](https://millionrounds.com/startup/dialybrid) - [**INTRAUMA S.P.A.** Rivoli · founded 2006](https://millionrounds.com/startup/intrauma-s-p-a) - [**Newronika S.p.A.** Cologno Monzese · founded 2016](https://millionrounds.com/startup/newronika-s-p-a) - [**KLISBio** Bresso · founded 2014](https://millionrounds.com/startup/klisbio) ## Is this your company? Add your raise, your deck and your story, and put Prothea Technologies in front of investors. Or tell us what we have wrong. [List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)